The treatment of community-acquired pneumonia is empirical in most cases and must cover a wide range of potential pathogens, such as Streptococcus pneumoniae, including penicillin-resistant strains, Haemophilus influenzae and intracellular microorganisms. The objective of this double-blind, randomized, parallel group study was to compare the efficacy and safety of sparfloxacin (400 mg loading dose, followed by 200 mg o.d.) with that of oral amoxycillin-clavulanic acid (500/125 mg t.i.d.) or oral erythromycin (1 g b.i.d.), during 7-14 days in 808 patients with confirmed community-acquired pneumonia. The overall success rates for sparfloxacin (87%), amoxycillin-clavulanic acid (80%) and erythromycin (85%) were similar in evaluable patients, and the equivalence hypothesis used for the statistical analysis showed at least an equivalent efficacy for the three antibiotics tested. The analysis of microbiologically documented infections (40% of the patients) showed that overall success rates were similar for S. pneumoniae and H. influenzae infections. Treatment withdrawal was necessary in 3.5, 2.5 and 7.7% of the patients treated with sparfloxacin, amoxycillin-clavulanic acid and erythromycin, respectively. This study indicates that sparfloxacin was at least as effective as amoxycillin-clavulanic acid or erythromycin in the treatment of mild-to-moderate community-acquired pneumonia and that the adverse effects were similar in the three groups.
To investigate the relation between lung
Diagnostic tests were only performed in 29% of cases. Chest radiographs were performed most frequently (22%), followed by peripheral blood white cell count (15%) and microbiological examination of sputum (7%), with major differences being found in the frequency of these tests both by clinical diagnosis and country. A change in initial antibiotic therapy was made in 12% of cases, with use of investigation being significantly linked to such changes.Second-and third-line antibiotics were significantly different to first-line therapy, with macrolides the most frequently prescribed second-line and quinolones the most frequently prescribed third-line antibiotics. Eur Respir J., 1996Respir J., , 9, 1596 Lower respiratory tract infections (LRTIs) are amongst the commonest illnesses of mankind, with an estimated annual incidence of 40 per 1,000 adults [1]. Of those seeking medical attention, most are managed in the community by general practitioners (GPs). Antibiotics are the mainstay of therapy, the use of which may be directed by the results of simple investigations. How frequently such investigations are performed in the management of LRTIs in the community, whether there are national differences in the use of such investigations, and the impact of their results on therapy, in particular antibiotic prescription, is not known. A multinational European survey of the management of LRTIs was carried out, and the results regarding the use of investigations and second-and third-line antibiotic therapy are presented here. MethodsThe design of the survey, data collection methods and methods of statistical analysis are detailed in the accompanying paper on first-line antibiotic therapy [2]. Briefly, between December 8, 1993, and January 24, 1994, a standardized questionnaire was administered to a random, but representative sample of GPs in France, Germany, Italy, Spain and the UK, identified by the "method of quotas" [2]. Information was sought about the last three or four adults seen, for whom the GP considered the diagnosis to be community-acquired LRTI. The criteria for this diagnosis were left to the judgement of the GP, since the aim of the study was to investigate normal practice, rather than altering practice by specifying definitions. The time since patient consultation was not recorded, but since the study was performed in the winter the delay between consultation and study is likely to have been short.In addition to questions about patient demographics, symptoms, clinical signs and antibiotic therapy, the questionnaire also sought the GP's presumptive clinical diagnosis. Four clinical categories were provided: community-acquired pneumonia (CAP); acute bronchitis (AB); exacerbation of chronic bronchitis (ECB); and viral LRTI, including influenza (VRTI). Again the criteria for each category were left to the judgement of the GP, but will be analysed as part of a future paper.Details about whether a chest radiograph (CXR), peripheral blood white cell count (WCC) and sputum sample (SPUTUM) had been obtained were recorded...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.